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Abstract
Background: Old age and diabetes mellitus are risk factors for vitamin deficiencies, weakness and falls.
Deficiencies of vitamin D, and possibly vitamin B12 and folate (which are associated with hyperhomocysteinaemia),
contribute to sarcopenia. Determination of the physical effects of vitamin deficiencies in specific groups of people
can help to guide public health policy with regard to vitamin supplementation.
Methods: A pilot cross-sectional study was conducted to determine the association of levels of vitamin D, vitamin
B12, folate and homocysteine with muscle strength, gait and fall history in 56 patients >65 years old with diabetes
mellitus in primary care in Singapore.
Hand-grip and leg-quadriceps strength measures were obtained and divided by body mass index (BMI).
The timed up-and-go and Tinetti tests were used to measure gait. A history of “at least one fall in the preceding
year” was obtained.
Results: Vitamin B12 deficiency (<150 pmol/l) was present in 43 % of patients, folate deficiency (<13.5 mmol/l) in
20 %, hyperhomocysteinaemia (≥15.0 μmol/l) in 52 % and vitamin D deficiency (<49.9 nmol/l) in 25 %.
Levels of vitamin D, vitamin B12 and homocysteine did not significantly predict muscle strength in regression
analyses.
Folate (B = 0.010, P < 0.01) and gender (B = 0.356, P < 0.001) predicted average grip strength corrected for BMI
(F(2,53) = 17.74, P < 0.001, R2 = 0.40)
Folate (B = 0.011, P < 0.05) and gender (B = 0.367, P < 0.001) also predicted average leg quadriceps strength
corrected for BMI (F(2,53) = 9.79, P < 0.001, R2 = 0.27).
Average leg strength and average leg strength corrected for BMI were both negatively associated with the risk of
having fallen in the preceding year (odds ratio (OR) = 0.89, 95 % CI 0.80–0.98, P < 0.05 and OR = 0.12, 95 % CI 0.02–0.
92, P < 0.05, respectively).
(Continued on next page)
Correspondence: andrew.wee@singhealth.com.sg
SingHealth Polyclinics, Marine Parade Polyclinic, Blk 80 Marine Parade Central,
#01-792, Singapore 440080, Singapore
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wee Nutrition Journal  (2016) 15:89 
DOI 10.1186/s12937-016-0208-3
(Continued from previous page)
Conclusions: The prevalence of vitamin deficiency was very high in our sample of patients >65 years old with
diabetes mellitus. Folate levels were significantly correlated with grip and leg strength (with correction for BMI). Leg
strength was positively correlated with gait measures and negatively correlated with a history of falls. The role of
folate in muscle weakness and falls warrants further study.
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Background
Singapore has an ageing population, with an increasing
prevalence of diabetes mellitus. In 2015, 11.8 % of the
population was ≥65 years old [1], and a health survey con-
ducted in 2010 found that 29.1 % of those aged 60–69
years had diagnosed diabetes mellitus [2]. In 2007, 36.3 %
of patients in the primary care polyclinic in Marine
Parade, where this study was conducted, were ≥65 years
old [unpublished data].
Old age and diabetes are associated with the incidence
and consequences of falls. A study conducted in 2011 by
the Singapore Ministry of Health on 2600 community-
dwelling individuals ≥60 years old in Marine Parade
showed that 78.4 % suffered from at least one chronic dis-
ease, and 15 % had fallen in the 12 months preceding the
survey [3]. In a prospective cohort study [4] of 63,257
Chinese men and women in Singapore, a strong dose-
dependent relationship was observed between the dur-
ation of diabetes mellitus and the risk of hip fracture, lead-
ing to the suggestion that the prevention of falls should be
an aspect of diabetes management. In a study involving
2847 individuals ≥65 years old presenting at the emer-
gency department of an acute-care general hospital in
Singapore, falls were the most common (13.9 %) present-
ing complaint [5].
Old age and diabetes mellitus are also associated with
deficiencies of vitamin B12 and vitamin D.
The prevalence of vitamin D deficiency in Singapore
has been reported to be 44 % in an inpatient rehabilita-
tion unit [6], 34.5 % among patients admitted to a local
hospital with hip fractures [7] and 14.3 % in an ethnic
Chinese cohort 45–74 years old [8].
In a UK-based study [9], the prevalence of vitamin
B12 deficiency was ~10 % in individuals 65–74 years
old and ~20 % in those ≥75 years old. Vitamin B12
deficiency is common in patients with diabetes melli-
tus because of its association with the first-line ther-
apy, metformin [10, 11].
In a cross-sectional study of 203 outpatients with type
2 diabetes mellitus at a US primary care clinic [12], the
prevalence of metabolically confirmed vitamin B12 defi-
ciency was 22 %, and patients receiving metformin had a
significantly lower serum level of vitamin B12 than those
not receiving metformin (314.4 pmol/l versus 389.3
pmol/l; P = 0.012).
In a cross-sectional study of 608 patients with
diabetes attending the Marine Parade Polyclinic’s
Family Physician (FP) Clinic, we found that one in
four had a vitamin B12 deficiency of <150 pmol/l
[unpublished data].
Vitamin D deficiency has a well-documented asso-
ciation with sarcopenia, muscle weakness and falls
[13–15], and the role of vitamin D in the regulation
of epigenetic DNA methylation is currently being in-
vestigated [16]. However, many of the falls that occur
with old age and diabetes mellitus could also be the
result of deficiencies of vitamin B12 and folate. Vita-
min B12 deficiency can cause neuropathy that can
lead to impaired balance and proprioception, along
with amyotrophy and subsequent sarcopenia, all of
which can contribute to falls [17]. Vitamin B12 defi-
ciency can also lead to depression with consequent
psychomotor retardation, contributing to subsequent
falls [18, 19]. Vitamin B12 deficiency has also been
associated with frailty [20], which is characterised by
reductions in weight, grip strength, endurance, physical
activity and walking speed, which could again contribute
to falls [21]. Elevation of serum levels of homocysteine (a
proxy for deficiencies in vitamin B12 and folate)
could, in turn, cause neuro-cardiovascular complica-
tions, such as cognitive decline and stroke [22], that
could predispose to falls. Homocysteine permanently
degrades the molecular structural integrity of colla-
gen, elastin and proteoglycans, causing predisposition
to muscular–skeletal mechanical instability, osteopor-
osis, falls and fractures [23–25]. The results of a
study conducted in Singapore [26] suggest that low
levels of folate and high levels of homocysteine are
associated with physical and functional decline, as
measured by Performance-Oriented Mobility Assess-
ment (POMA) and Instrumental Activities of Daily
Living (IADL) scores.
Apart from a few case reports [27–32], no published
studies have directly linked deficiencies of vitamin B12
and folate to the occurrence of falls.
The aim of this pilot study was to identify any associ-
ation between muscle strength and gait and balance
assessments and levels of serum vitamin B12 and folate
in patients >65 years old with diabetes mellitus in a
primary care polyclinic in Singapore.
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Methods
Study population
Ethics approval was obtained from SingHealth Centra-
lised Institutional Review Board and all participants pro-
vided written informed consent.
Participants were patients >65 years old and diagnosed
with diabetes mellitus for ≥1 year at the Marine Parade
polyclinic, which provides public primary health care to
the socio-economically heterogeneous south-eastern re-
gion of the city-state of Singapore. A convenience sam-
pling strategy was used where subjects were recruited as
they presented at the clinic for treatment related to
diabetes mellitus. They were referred for recruitment by
doctors or nurses after diabetic retinal photography, dia-
betic foot screening or clinic consultations for diabetes
mellitus. Disproportionate stratified sampling by gender
was used to ensure equal numbers of male and female
participants, and 56 patients (28 male and 28 female)
were recruited. A total of 200 patients were excluded at
the pre-screening phase because of recent acute illness,
malignancy, severe neuromuscular disorders (such as
major stroke, Parkinson’s disease, inability to walk inde-
pendently despite assistive devices), inconsistent vitamin
supplementation in the preceding year, illiteracy or
inability or refusal to give informed consent. Regular
patients of the Principal Investigator were also excluded.
Study phases
The first phase was performed in 2012 with the recruit-
ment of 11 patients, and provided provisional data to
enable calculation of the sample size for the second
phase. The second phase was performed in 2014 with
the recruitment of an additional 45 patients, and in-
volved a change in the device for measuring lower-limb
strength, and the inclusion of a swaymeter to assess
balance via body sway. Serum albumin and total protein
were also measured in the second phase.
Measurements
Each patient was interviewed and assessed (without fast-
ing) in one session by the Principal Investigator and a
trained Research Assistant. Overnight fasting blood sam-
ples were then obtained the following day and analysed
by the Singapore General Hospital Laboratory.
Laboratory measurements
Serum vitamin B12 and folate were analysed by Access
Immunoassay Systems 33000 and A98032, respectively
(Beckman Coulter, Brea, CA, USA). Homocysteine was
analysed with the ARCHITECT Homocysteine Assay
1L71 (Abbott, Wiesbaden, Germany). 25-OH-vitamin D
was measured with the 25-Hydroxyvitamin D 125I RIA
Kit (68100E; DiaSorin Inc, Stillwater, MN, USA). Serum
albumin and total protein were measured with the
ALB2: ACN 8413 and TP2: ACN 8678 in vitro tests,
respectively, on a cobas® c 701/702 analyser (Roche
Diagnostics, Mannheim, Germany).
Vitamin B12 deficiency and elevated homocysteine
(hyperhomocysteinaemia) were defined as <150 pmol/l
[17, 18, 33, 34] and ≥15.0 μmol/l, respectively [35]. Fol-
ate deficiency was defined as <13.5 nmol/l based on the
laboratory’s chosen definition, vitamin D deficiency as
<49.9 nmol/l and vitamin D insufficiency as ≥49.9 nmol/
l and <74.1 nmol/l [13].
Physical performance tests to assess muscle strength, gait
and balance
We used the POMA scoring system to assess perform-
ance [36, 37], which has been shown to accurately assess
impairments in gait and balance that lead to increased
fall risk [38]. Timed up-and-go (TUG) [39] and 6-m
fast-gait-speed tests were also performed. The TUG test
measured the time for barefooted patients sitting in a
standard armchair to get up and walk around a mini
traffic cone 3 m away and then to walk back to sit in the
chair. The 6-m fast-gait-speed test assessed the time
needed to walk 6 m at maximum speed [40, 41].
Leg strength was measured with the patient seated on
a chair with hips and knees flexed at 90°. A foam-
padded dynamometer was placed on the shin 10 cm
above the lateral malleolus, and the patient exerted a
maximal extension force on the pad. For the 11 patients
of the first phase of this study, measurements were made
with a factory-calibrated Lafayette hand-held dynamom-
eter. However, the reliability of this device is affected by
the strength of the patient [42], and its use is physically
strenuous and has a risk of strain injury. A calibrated
stationary dynamometer was obtained from the group of
Professor Stephen R. Lord at Neuroscience Research
Australia (Sydney, Australia) for leg-strength measure-
ment in the remaining 45 patients of the second phase.
Leg quadriceps strength was measured in kilogram-
force (kgf; ~9.8 N per 1 kgf). The dominant and non-
dominant legs were assessed three times each with 10–
20 s between each maximal extension effort. The mean
strength for both legs and the mean strength and peak
performance for each leg were obtained. A separate
measure was obtained by dividing mean strength by
body mass index (BMI), to correct for body habitus.
Hand-grip strength in both the dominant and non-
dominant arms was measured with the Jamar® grip-
strength dynamometer (Sammons Preston Rolyan,
Bolingbrook, IL, USA) [43–45]. The patient was seated,
with shoulders adducted and neutrally rotated, and
elbow flexed at 90°, with the forearm in neutral position
and the wrist between 0 and 30° of dorsiflexion and be-
tween 0 and 15° of ulnar deviation. Mean strength for
both forearms and mean strength and peak performance
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of each forearm were obtained. A separate measure was
obtained by dividing mean strength by BMI.
A Lord swaymeter (with foam) was obtained from the
Lord group at Neuroscience Research Australia, for as-
sessment of the 45 patients in the second phase of the
study. This device provides valid and reliable measure-
ments for assessing fall risk in a range of health-care set-
tings [46], by determining anterior–posterior and lateral
sway displacements, with a 40 cm rod attached to the
patient’s waist on one end and mounted with a pen on
the opposite end. The pen records the sway on graph
paper. Patients had their balance tested three times
with each of the four combinations of having both
eyes open or shut and standing on the floor or on
foam. The sway area, which is a product of the anter-
ior–posterior displacement and the lateral displace-
ment after 30 s of standing, was measured for each
attempt, and the mean of each set of three measure-
ments was determined.
These measurement tools were chosen also because of
their portability, validation, reliability, simplicity of use
and potential for future clinical applications in the pri-
mary health-care setting, where high loads of patients
are the norm, and quick and reliable assessment tools
are required for risk stratification.
Other variables
Other information that was collected included physical
characteristics and history of chronic disease, informa-
tion on medication and lifestyle (Table 1). Data were
collected from medical records on glycosylated haemo-
globin (HbA1c, measured with the A1-W3: ACN 881 in
vitro test on a cobas® analyser), LDL cholesterol (from
the Friedewald equation, with Total Cholesterol mea-
sured with CHO2I: ACN 8798 and CHO2A: ACN 8433
in vitro tests, HDL Cholesterol measured with the
HDLC3: ACN 8435 in vitro test, Triglycerides measured
with the TRIGL: ACN 8781 in vitro test; cobas® ana-
lyser), alanine aminotransferase (ALT, ALTL: ACN 8685
in vitro test; cobas® analyser) and estimated creatinine
clearance (from the Cockcroft–Gault equation, with cre-
atinine measured with the CREJ2: ACN 8690 in vitro
test; cobas® analyser). These measurements were taken
from the most recent laboratory tests performed on all
patients as part of routine diabetic care within the
preceding year.
Other tests were administered, including the Michigan
Neuropathy Screening Instrument (MNSI© University of
Michigan, 2000), for assessment of distal symmetrical
peripheral neuropathy. The Horwell® Neurothesiometer
[47], which tests the vibration perception threshold
(VPT) of the tip of the big toe (from 0 to 50 V), was ap-
plied to both feet. The Semmes–Weinstein Monofila-
ment Test [48, 49], the Barthel Index of Activities of
Daily Living (BADL) [50–52] and the IADL [53] were
also used.
Patients were also asked if they had fallen at least once
in the preceding year. The definition of a fall was taken
as “an unintentional change in position resulting in com-
ing to rest on the ground or another lower level, and not
as a result of a major intrinsic event (e.g., stroke, syn-
cope) or overwhelming hazard (e.g., car accident)” [46].
Sample-size calculation
There has hitherto been no similar study associating
levels of vitamin B12 and folate with muscle strength,
gait and balance measures in older people with diabetes
mellitus in Singapore. Thus, to ascertain an effect size,
provisional analysis of the first 11 patients showed a
lower vitamin B12 level to be associated with a longer
time to complete the TUG test with a Pearson correl-
ation of 0.34. With a type I error of 0.05 and power of
0.8, a total of 66 patients should have been recruited to
validate this level of correlation. However, a sample size
of 56 patients was chosen, as a reasonable number for a
pilot study. This number of patients would still yield sig-
nificant results at a Pearson correlation of 0.37 or better.
In the first 11 patients, a high level of correlation was
seen between the average grip strength (corrected for
BMI) and serum folate (r = 0.85) and between the aver-
age corrected leg strength and serum folate (r = 0.71).
Moreover, serum folate per se strongly predicted average
corrected leg strength (B = 0.021, P < 0.05) and average
corrected grip strength (B = 0.022, P < 0.01) in bivariate
analysis for these 11 patients. However, these stronger
correlations were not used for the calculation of sample
size, which was instead based on the more conservative
approach.
Statistical analysis
Group comparisons for categorical and continuous vari-
ables were performed using chi-square tests, t-tests and
ANOVA where appropriate. Fisher’s exact test was used
to reconfirm any significant results from a chi-square
test because of the small sample size. When the patient-
count per cell was less than five, only Fisher’s exact test
was used. Serum levels of vitamin B12, folate, homocyst-
eine and 25-OH-vitamin D were also split into high
versus low values based on accepted cut-offs, for further
analysis.
Associations with muscle strength, gait and balance
measures were also assessed with multivariable linear
and logistic regression methods in which serum vitamin
B12, folate, homocysteine and 25-OH-vitamin D were
analysed as continuous predictive variables. Potential
interactions between these predictive variables were
explored by adding multiplicative interaction terms.
Variance inflation factors were analysed after regression
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Table 1 Baseline characteristics of the 56 patients according to gender and folate
Women (n = 28) [n
(%) or mean ± SD]
Men (n = 28) [n
(%) or mean ± SD]
P value Folate deficiency
(<13.5 nmol/l) (n = 11)
[n (%) or mean ± SD]
Folate normal (≥13.5
nmol/l) (n = 45) [n (%)
or mean ± SD]
P value
Vitamin B12 level (pmol/l) 205 ± 136 200 ± 103 ns 224 ± 142 197 ± 114 ns
Vitamin B12 deficiency (<150 pmol/l) 13 (46 %) 11 (39 %) ns 5 (45 %) 19 (42 %) ns
Folate level (nmol/l) 21.8 ± 10.8 21.1 ± 9.3 ns 10.8 ± 2.1 24.0 ± 9.5 <0.001
Folate deficiency (<13.5 nmol/l) 7 (25 %) 4 (14 %) ns 11 (100 %) 0 (0 %) <0.001
25-OH-vitamin D level (nmol/l) 63.6 ± 17.7 63.1 ± 20.5 ns 59.2 ± 25.5 64.5 ± 17.3 ns
25-OH-vitamin D deficiency (<49.9 nmol/l) 9 (32 %) 5 (18 %) ns 4 (36 %) 10 (22 %) ns
Homocysteine level (μmol/l) 16.8 ± 9.5 16.9 ± 6.4 ns 17.4 ± 6.9 16.8 ± 8.3 ns
Hyperhomocysteinaemia (≥15.0 μmol/l) 14 (50 %) 15 (54 %) ns 7 (64 %) 22 (49 %) ns
Ethnicity (n and % of respective column group)
Chinese 24 (85 %) 19 (68 %) ns 8 (73 %) 35 (78 %) ns
Malay 2 (7 %) 1 (4 %) ns 0 (0 %) 3 (7 %) ns
Indian 1 (4 %) 4 (14 %) ns 3 (18 %) 3 (7 %) ns
Eurasian and Others 1 (4 %) 4 (14 %) ns 1 (9 %) 4 (9 %) ns
Age (years)
Overall mean age 72 ± 5 71 ± 4 ns 72 ± 5 71 ± 5 ns
65–69 years old (n and % of
respective column group)
10 (36 %) 13 (46 %) ns 4 (36 %) 19 (42 %) ns
70–74 years old (n and % of
respective column group)
11 (39 %) 9 (32 %) ns 5 (46 %) 15 (33 %) ns
75–79 years old (n and % of
respective column group)
4 (14 %) 5 (18 %) ns 1 (9 %) 8 (18 %) ns
80–84 years old (n and % of
respective column group)
3 (11 %) 1 (4 %) ns 1 (9 %) 3 (7 %) ns
Height (m) 1.52 ± 0.05 1.65 ± 0.07 <0.001 1.55 ± 0.11 1.59 ± 0.09 ns
Weight (kg) 55.6 ± 9.0 67.9 ± 10.2 <0.001 64.4 ± 14.4 61.1 ± 10.6 ns
BMI (kg/m2) 24.2 ± 4.0 24.9 ± 3.78 ns 26.6 ± 3.5 24.1 ± 3.8 ns
History of chronic disease
Hypertension 24 (85 %) 21 (75 %) ns 10 (91 %) 35 (78 %) ns
Hyperlipidaemia 26 (93 %) 27 (96 %) ns 11 (100 %) 42 (93 %) ns
Ischaemic heart disease 5 (19 %) 7 (25 %) ns 1 (11 %) 11 (24 %) ns
Stroke 3 (11 %) 0 (0 %) ns 1 (9 %) 2 (4 %) ns
Cancer (exclusion criterion) 0 (0 %) 0 (0 %) ns 0 (0 %) 0 (0 %) ns
Chronic obstructive pulmonary disease 0 (0 %) 0 (0 %) ns 0 (0 %) 0 (0 %) ns
Number of chronic medications
(excluding supplements)
5.8 ± 1.6 6.0 ± 2.4 ns 6.8 ± 2.0 5.7 ± 2.0 ns
Vitamin–mineral supplementation
Supplementation of any type 21 (75 %) 13 (46 %) <0.05 7 (64 %) 27 (60 %) ns
Supplementation containing vitamin
B12
4 (14 %) 3 (11 %) ns 4 (36 %) 3 (7 %) <0.05
Supplementation containing folate 3 (11 %) 2 (7 %) ns 2 (18 %) 3 (7 %) ns
Supplementation containing vitamin D 12 (43 %) 4 (14 %) <0.05 5 (45 %) 11 (24 %) ns
Supplementation containing calcium 13 (46 %) 5 (18 %) <0.05 5 (45 %) 13 (29 %) ns
Taking proton-pump inhibitor 6 (21 %) 7 (25 %) ns 4 (36 %) 9 (20 %) ns
Taking Histamine H2 antagonist 0 (0 %) 3 (11 %) ns 1 (9 %) 2 (4 %) ns
Taking metformin 25 (89 %) 27 (96 %) ns 11 (100 %) 41 (91 %) ns
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analyses to ensure that collinearity did not exist, because
homocysteine shares the same metabolic pathway as
vitamin B12 and folate.
The mean scores for the history and physical assess-
ments of the MNSI, neurothesiometer readings and BADL
were analysed for difference using t-tests. In addition, the
results of the BADL (maximum score 20), IADL (max-
imum score 8), POMA–balance (POMA B; maximum
score 16) and POMA–gait (POMA G; maximum score
12) were separated into those with and without the
maximum score, and differences were analysed using chi-
square and Fisher’s exact tests, as appropriate.
Physical measurements for muscle strength, gait and
balance, BADL, IADL, tests for neuropathy and fall
history were analysed as dependent variables. Dependent
variables were analysed as continuous, categorical or or-
dinal variables, as appropriate. Characteristics that could
affect physical performance measures (the presence or
absence of smoking and/or alcohol consumption, esti-
mated creatinine clearance, serum total protein, serum
albumin, ALT, age, gender, self-reported sleep, number
of chronic medications) were also explored as predictive
variables in various models. Predictive variables were
first individually paired with each dependent variable
and analysed for correlation. Regression models were
then analysed using forward and backward selection. To
prevent overfitting because of the small sample size, only
two parsimonious models are described (Table 2), based
on statistical significance, the aims of this study and
biological plausibility. Standardized and unstandardized
Table 1 Baseline characteristics of the 56 patients according to gender and folate (Continued)
Metformin duration >1 year 24 (85 %) 25 (89 %) ns 11 (100 %) 38 (84 %) ns
Metformin 1-year cumulative dose
(g/year)
543 ± 420 538 ± 311 ns 684 ± 250 505 ± 318 ns
Metformin latest daily dose (g/day) 1.49 ± 0.84 1.57 ± 0.87 ns 1.82 ± 0.73 1.46 ± 0.87 ns
Taking sulphonylureas 15 (54 %) 18 (64 %) ns 7 (64 %) 26 (58 %) ns
Taking dipeptidyl peptidase-4 inhibitors 3 (11 %) 4 (14 %) ns 2 (18 %) 5 (11 %) ns
Taking insulin 3 (11 %) 2 (7 %) ns 0 (0 %) 5 (11 %) ns
Smoking 1 (4 %) 4 (14 %) ns 0 (0 %) 5 (11 %) ns
Consumption of alcohol at least 1 unit per
week
0 (0 %) 8 (29 %) <0.01 2 (18 %) 6 (13 %) ns
Self-reported sleep per day (h) 7.2 ± 1.6 6.8 ± 1.0 ns 6.7 ± 1.2 7.0 ± 1.4 ns
HbA1c (%) 7.3 ± 0.6 7.2 ± 0.7 ns 7.2 ± 0.9 7.3 ± 0.6 ns
aEstimated creatinine clearance (ml/min)
(Cockcroft–Gault)
62.0 ± 19.8 68.0 ± 25.1 ns 70.0 ± 27.1 63.8 ± 21.5 ns
aLDL cholesterol level (mmol/l) 2.25 ± 0.61 2.18 ± 0.79 ns 2.59 ± 0.97 2.13 ± 0.60 ns
Total protein (g/l) [for patients 12–56 only;
22 male, 23 female]
72.3 ± 3.0 71.0 ± 3.8 ns 72.7 ± 3.4 71.5 ± 3.5 ns
Total albumin (g/l) [for patients 12–56
only; 22 male, 23 female]
45.0 ± 2.4 45.4 ± 2.0 ns 44.7 ± 1.3 45.2 ± 2.4 ns
Neurothesiometer VPT (V) (average of
both feet)
13.21 ± 5.73 13.55 ± 6.12 ns See Table 3 See Table 3 -
Average lower-limb strength (kgf) (average
of both limbs, three attempts per limb)
17.14 ± 4.82 26.79 ± 11.78 <0.001 See Table 3 See Table 3 -
Average lower limb strength/BMI (m2) 0.73 ± 0.24 1.09 ± 0.41 <0.001
Average grip strength (kgf) (average of
both hands, three attempts per hand)
16.22 ± 3.29 25.54 ± 7.78 <0.001 See Table 3 See Table 3 -
Average grip strength/BMI (m2) 0.69 ± 0.19 1.04 ± 0.33 <0.001
6-m fast-gait speed (m/s) (average of two
trials)
1.02 ± 0.27 1.17 ± 0.28 ns See Table 3 See Table 3 -
Timed up-and-go test (s) (average of two
trials)
11.36 ± 5.72 9.53 ± 2.72 ns See Table 3 See Table 3 -
Values are the mean ± SD or number (%) unless otherwise indicated
Pearson chi-square test and Fisher’s exact test (where appropriate) were used for categorical variables and t-test was used for continuous variables
For 25-OH-vitamin D, divide by 2.496 to convert from nmol/l to μg/l [68]. For vitamin B12, divide by 0.738 to convert from pmol/l to pg/ml [68]
For folate, divide by 2.266 to convert from nmol/l to μg/l [68]. For homocysteine, divide by 7.397 to convert from μmol/l to ml/l [68]
Abbreviations: BMI body mass index, LDL low-density lipoprotein, ns not significant, SD standard deviation, VPT vibration perception threshold
aObtained from case records
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Table 2 Regression analyses of associations of variables with leg strength, grip strength, fast-gait speed and timed up-and-go (TUG) times
Determinants of strength
measures (leg and grip)
Regression of average leg strength/BMI Regression of average grip strength/BMI
Model 1, F(6, 49) = 3.30,
P < 0.01
Model 2, F(2, 53) = 9.79, P < 0.001 Model 1, F(6, 49) = 6.25, P < 0.001 Model 2, F(2, 53) = 17.74, P < 0.0001
R2 = 0.29, adjusted R2 = 0.20 R2 = 0.27, adjusted R2 = 0.24 R2 = 0.43, adjusted R2 = 0.36 R2 = 0.40, adjusted R2 = 0.38
β B (SE) P β B (SE) P β B (SE) P β B (SE) P
Gender (men = 1, women = 0) 0.4450 0.3600 (0.0982) 0.001 0.4537 0.3670 (0.0950) <0.001 0.5406 0.3451 (0.0691) <0.001 0.5573 0.3558 (0.0679) <0.001
Age −0.0727 −0.0065 (0.0117) ns - - - −0.1792 −0.0127 (0.0082) ns - - -
Folate 0.1926 0.0078 (0.0057) ns (0.173) 0.2681 0.0109 (0.0048) 0.026 0.3084 0.0099 (0.0040) 0.017 0.3194 0.0102 (0.0034) 0.004
Vitamin B12 −0.0868 −0.0003 (0.0005) ns - - - −0.0138 −0.00004(0.0003) ns - - -
Vitamin D 0.1036 0.0022 (0.0028) ns - - - −0.0076 −0.0001(0.0020) ns - - -
Homocysteine −0.0774 −0.0039 (0.0067) ns - - - 0.0515 0.0021(0.0047) ns - - -
Determinants of speed
measures (gait speed)
Regression of gait speed on average leg strength Regression of gait speed on average leg strength/BMI
Model 1′, F(5, 50) = 4.67, P <0.05 Model 2′, F(2, 53) = 11.89, P < 0.001 Model 1’, F(5, 50) = 6.09, P < 0.001 Model 2’, F(2, 53) = 16.00, P < 0.0001
R2 = 0.32, adjusted R2 = 0.25 R2 0.31, adjusted R2 = 0.28 R2 = 0.38, adjusted R2 = 0.32 R2 = 0.38, adjusted R2 = 0.35
β B (SE) P β B (SE) P β B (SE) P β B (SE) P
Average leg strength 0.4546 0.0126 (0.0330) <0.001 0.4655 0.0129 (0.032) <0.001 - - - - - -
Average leg strength/BMI - - - - - - 0.5291 0.3661 (0.0801) <0.001 0.5347 0.3699 (0.0755) <0.001
Age −0.2979 −0.0185 (0.0760) 0.018 −0.2788 −0.0174 (0.0071) 0.018 −0.2541 −0.0158 (0.0073) 0.035 −0.2491 −0.0155 (0.0068) 0.026
Vitamin B12 −0.0269 −0.0006 (0.0003) ns - - - 0.0097 0.00002 (0.0003) ns - - -
Vitamin D 0.0848 0.0013 (0.0018) ns - - - 0.0448 0.0007 (0.0017) ns - - -
Homocysteine 0.0044 0.0002 (0.0043) ns - - - 0.0149 0.0005 (0.0041) ns - - -
Determinants of speed
and balance measures (TUG)
Regression of TUG on average leg strength Regression of TUG on average leg strength/BMI
Model 1', F(5, 50) = 3.20, P < 0.05 Model 2', F(2, 53) = 7.57, P < 0.01 Model 1', F(5, 50) = 4.24, P < 0.01 Model 2', F(2, 53) = 10.38, P < 0.001
R2 = 0.24, adjusted R2 = 0.17 R2 0.22, adjusted R2 = 0.19 R2 = 0.30, adjusted R2 = 0.23 R2 = 0.28, adjusted R2 = 0.25
β B (SE) P β B (SE) P β B (SE) P β B (SE) P
Average leg strength −0.3487 −0.1555 (0.0559) 0.008 −0.3519 −0.1569 (0.0541) 0.005 - - - - - -
Average leg strength/BMI - - - - - - −0.4315 −4.7901 (1.3656) 0.001 −0.4230 −4.7737 (1.3000) 0.001
Age 0.3026 0.3022 (0.1285) 0.023 0.2934 0.2932 (0.1212) 0.019 0.2649 0.2647 (0.1247) 0.039 0.2683 0.2681 (0.1170) 0.026
Vitamin B12 −0.0492 −0.0019 (0.0051) ns - - - −0.0810 −0.0030 (0.0049) ns - - -
Vitamin D −0.1251 −0.0298 (0.0301) ns - - - −0.0901 −0.0214 (0.0292) ns - - -










regression coefficients (β and B, respectively), corre-
sponding standard errors (SE) and adjusted R2 are pre-
sented, along with F (the ratio of mean regression sum
of squares to mean error sum of squares, shown with
the number of degrees of freedom in the numerator and
the denominator).
The average leg strength (corrected for BMI) and the
average corrected grip strength were individually ana-
lysed in two linear regression models.
 Model 1: Regression on gender, age, vitamin B12,
folate, vitamin D and homocysteine.
 Model 2: Regression on gender and folate.
Fast-gait speed and TUG test results were analysed in
two further linear regression models.
 Model 1′: Regression on age, vitamin B12, vitamin
D, homocysteine, leg strength (corrected and
uncorrected for BMI).
 Model 2′: Regression on age and leg strength
(corrected and uncorrected for BMI).
In Models 1′ and 2′, gender and folate were not in-
cluded as predictive variables, to avoid collinearity with
the leg-strength measures.
The data were analysed using STATA 13.0 statistical




The baseline characteristics of men and women in the
study are shown in Table 1. Men had significantly higher
baseline physical and anthropometric measurements than
women (P < 0.001). Twenty-nine per cent of men con-
sumed at least one unit of alcohol per day whereas, as ex-
pected, none of the women consumed any (P < 0.01).
Women were more likely to consume calcium and
vitamin D supplements than men (P < 0.05). However,
women’s baseline vitamin D levels (63.6 ± 17.7 nmol/l)
were similar to men’s (63.1 ± 20.5 nmol/l), and women
had a (non-significantly) greater prevalence of vitamin D
deficiency (32 %) than men (18 %).
Table 1 also shows the baseline characteristics of
patients with and without folate deficiency. 36 % of
patients with folate deficiency had been taking supple-
ments containing vitamin B12 compared to just 7 %
of patients with normal folate (P < 0.05).
Vitamin B12 deficiency was present in 43 % of pa-
tients, folate deficiency in 20 %, and both deficiencies
in 9 %. Hyperhomocysteinaemia was present in 52 %
of patients, vitamin D deficiency in 25 % and vitamin
D insufficiency in 48 % (Fig. 1). No significant
differences were seen between the genders for these
measures.
Bivariate comparisons
Women with folate deficiency had significantly lower
(P < 0.05) average leg strength (with and without cor-
rection for BMI) and average grip strength (P < 0.01)
than women with normal folate (Table 3). Folate sta-
tus did not affect male strength, but men with hyper-
homocysteinaemia had significantly lower average leg
strength (P < 0.05) and average grip strength (P < 0.01),
with and without BMI correction.
On the history component of the MNSI, 44 patients
(79 %) reported having muscle cramps in the legs and/or
feet, and 16 patients (29 %) reported feeling weak all
over most of the time. No significant association was
found between these statements and levels of vitamins
and homocysteine. Folate deficiency was associated with
a consistent, but nonsignificant, trend towards poorer
scores in both the history and physical assessment com-
ponents of the MNSI.
Neurothesiometer readings were consistently (but
non-significantly) lower in patients with vitamin defi-
ciencies or hyperhomocysteinaemia than in individuals
with normal levels. Similarly, the proportion of individ-
uals who reported having fallen at least once in the pre-
ceding year was consistently (but non-significantly)
higher in the presence of vitamin deficiencies or hyper-
homocysteinaemia than with normal levels. Logistic re-
gression of a positive fall history in the preceding year
with levels of vitamin D, vitamin B12, folate and homo-
cysteine did not reveal any significant associations. How-
ever, logistic regression demonstrated that average leg
strength had a significant association with the risk of a
positive fall history (odds ratio (OR) = 0.89 per 1 kgf
increase in uncorrected leg strength, 95 % CI 0.80–0.98,
P < 0.05; OR = 0.12 per 1 m2 increase in leg strength cor-
rected for BMI, 95 % CI 0.02–0.92, P < 0.05). Thus the
greater the leg strength, the lower the odds of having a
positive fall history. The OR and statistical significance
were minimally affected when controlling for age and
gender (data not shown).
Patients with folate deficiency had a significantly lower
mean BADL score than patients with normal folate levels
(19.09 ± 1.37 versus 19.87 ± 0.46, P < 0.01). Similarly, 45 %
of folate-deficient patients had a less-than-perfect BADL
score, compared with only 9 % of folate-sufficient patients
(P = 0.01 by Fisher’s exact test). Similar negative effects of
folate deficiency on the proportion of patients with
perfect scores were seen in POMA B (P < 0.05) and
POMA G (P = 0.05), with chi-square tests. Patients
with folate deficiency and those with hyperhomocys-
teinaemia were also less likely than those with normal
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levels to have a perfect score in the IADL (P < 0.05
for both chi-square and Fisher’s exact tests) (Table 3).
When patients were analysed according to gender, fol-
ate deficiency had a significant (P < 0.05) negative effect
on 6-m fast-gait speeds and TUG times in women, but
not in men. Combining men and women in the analysis
increased the level of significance for this effect (P < 0.01
for both measures by t-test). No significant association
between these variables was demonstrated by regression
analysis (data not shown). No significant effect or trend
was observed between vitamin and homocysteine status
and the results of sway-area analyses (data not shown).
Regression analyses
Regression analyses were performed to identify vari-
ables associated with leg strength and grip strength.
The values of leg strength and grip strength cor-
rected for BMI had a kurtosis of 3.17 and 2.72, re-
spectively, and a positive skew of 0.69 and 0.78,
respectively. Regression analyses were performed
with these values both untransformed and natural-
log-transformed. Value transformation did not affect
significance, and untransformed values were used in
the statistical analyses.
Two regression models were tested for the associ-
ation of leg strength and grip strength (both corrected
for BMI) with patient characteristics. Model 1 included
multiple variables, of which gender predicted leg
strength (P = 0.001) and grip strength (P < 0.001), and
folate predicted grip strength (P = 0.017). Model 2 only
included gender and folate levels, both of which
predicted average leg strength (F(2,53) = 9.79, P < 0.001,
R2 = 0.27) and grip strength (F(2,53) = 17.74, P < 0.001,
R2 = 0.40) (Table 2, Fig. 2).
Two further regression models were tested for the as-
sociation of variables with 6-m fast-gait speed and TUG
results. Model 1′ included multiple variables, of which
leg strength (both uncorrected and corrected for BMI)
and age predicted both fast-gait speed and TUG time.
Model 2′ only included leg strength (corrected and un-
corrected values were analysed separately) and age, both
of which predicted fast-gait speed and TUG time
(Table 2).
Discussion
Vitamin B12 and folate are involved in the conversion of
homocysteine to methionine (Fig. 3), and hyperhomo-
cysteinaemia is a marker for vitamin B12 deficiency.
Many factors that predispose an individual to vitamin
B12 deficiency also predispose to vitamin D deficiency.
These factors include meat-deficient diets, malabsorp-
tion and old age. Among 56 patients >65 years old with
diabetes mellitus at a polyclinic in Singapore, we found a
high prevalence of deficiencies of vitamin B12, folate
and vitamin D, as well as hyperhomocysteinaemia.
In our cohort, more women than men took calcium
and vitamin D supplements (Table 1), presumably be-
cause of greater awareness of the need for the preven-
tion of osteoporosis in women [54, 55]. These
supplements typically supply 200–400 IU of vitamin D3
per day in combination with calcium carbonate. Despite
this level of supplementation, mean levels of vitamin D
were very similar in men and women. However, almost
twice as many women as men were vitamin D deficient,
although this difference was not statistically significant.
In a study of 134 inpatients ≥65 years old in a rehabilita-
tion centre in Singapore, although 26.9 % reported
taking calcium and/or vitamin D supplementation, 44 %
Fig. 1 Venn diagram of the deficiencies in vitamin B12, folate, and vitamin D (n = 56 patients)
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strength (kgf) (both genders)
21.50 ± 8.40 22.70 ± 11.02 ns 17.22 ± 11.6 23.4 ± 9.2 ns, (0.06) 20.36 ± 7.05 22.78 ± 10.7 ns 20.22 ± 6.21 24.29 ± 12.55 ns
Average non-dominant-leg
strength (kgf) (both genders)
21.64 ± 12.0 21.84 ± 10.60 ns 19.39 ± 14.58 22.33 ± 10.19 ns 18.93 ± 7.66 22.70 ± 11.95 ns 19.92 ± 6.51 23.72 ± 14.39 ns
Average leg strength (kgf)
(men)
26.21 ± 2.78 27.16 ± 11.48 ns 25.76 ± 19.20 26.96 ± 10.7 ns 21.7 ± 10.5 27.90 ± 11.96 ns 22.31 ± 6.43 31.96 ± 14.4 <0.05
Average leg strength (kgf)
(women)
17.63 ± 4.36 16.72 ± 5.31 ns 14.04 ± 5.14 18.18 ± 4.36 <0.05 18.49 ± 4.79 16.50 ± 4.83 ns 17.67 ± 4.19 16.62 ± 5.49 ns
Average leg strength/BMI
(m2) (men)
1.09 ± 0.44 1.09 ± 0.49 ns 0.95 ± 0.61 1.11 ± 0.45 ns 0.92 ± 0.42 1.13 ± 0.47 ns 0.91 ± 0.24 1.30 ± 0.57 <0.05
Average leg strength/BMI
(m2) (women)




20.38 ± 8.45 23.23 ± 7.70 ns 19.99 ± 10.84 22.50 ± 7.32 ns 21.02 ± 8.69 22.34 ± 7.94 ns 20.05 ± 5.26 24.11 ± 9.97 ns, (0.06)
Average non-dominant
hand-grip strength (kgf) (both
genders)
19.32 ± 7.64 20.10 ± 7.54 ns 18.76 ± 10.60 20.01 ± 6.70 ns 20.26 ± 7.26 19.60 ± 7.68 ns 18.37 ± 5.04 21.27 ± 9.37 ns
Average grip strength (kgf)
(men)
23.52 ± 9.67 26.86 ± 6.24 ns 30.39 ± 10.38 24.74 ± 7.23 ns 28.43 ± 7.06 24.92 ± 7.93 ns 21.34 ± 4.79 30.40 ± 7.85 <0.001
Average grip strength (kgf)
(women)
16.75 ± 3.91 15.78 ± 2.69 ns 13.07 ± 2.56 17.28 ± 2.82 <0.01 16.31 ± 3.62 16.19 ± 3.22 ns 16.93 ± 3.62 15.53 ± 2.87 ns
Average grip strength/BMI
(m2) (men)
0.97 ± 0.33 1.08 ± 0.34 ns 1.12 ± 0.29 1.03 ± 0.34 ns 1.18 ± 0.30 1.00 ± 0.34 ns 0.87 ± 0.22 1.24 ± 0.33 <0.01
Average grip strength/BMI
(m2) (women)
0.71 ± 0.24 0.67 ± 0.14 ns 0.51 ± 0.14 0.75 ± 0.17 <0.01 0.64 ± 0.16 0.71 ± 0.21 ns 0.67 ± 0.15 0.72 ± 0.23 ns
Michigan Neuropathy
Screening Instrument
(history: maximum severity of
13 points)




maximum severity of 10
points)
2.10 ± 1.62) 2.73 ± 1.56 ns 3.27 ± 1.49 2.27 ± 1.58 ns, (0.06) 2.57 ± 1.33 2.43 ± 1.90 ns 2.19 ± 1.52 2.76 ± 1.66 ns
Neurothesiometer VPT
score right foot (V)
13.73 ± 6.01 11.8 ± 4.39 ns 15.11 ± 5.90 12.02 ± 4.88 ns 12.86 ± 4.87 12.55 ± 5.34 ns 14.18 ± 6.21 10.96 ± 3.13 <0.05
Neurothesiometer VPT
score left foot (V)
15.50 ± 8.44 13.09 ± 6.42 ns 17.30 ± 8.17 13.34 ± 7.05 ns 15.32 ± 7.25 13.72 ± 7.46 ns 14.93 ± 8.08) 13.26 ± 6.59) ns
Neurothesiometer VPT
score average (V)
14.61 ± 6.95 12.44 ± 4.84 ns 16.21 ± 6.34 12.68 ± 5.61 ns 14.09 ± 5.77 13.14 ± 5.97 ns 14.55 ± 6.71) 12.11 ± 4.63) ns
History of having fallen
at least once in the
preceding year
7 (Yes) 7 (Yes) ns 5 (Yes) 9 (Yes) ns 4 (Yes) 10 (Yes) ns 9 (Yes) 5 (Yes) ns
17 (No) 25 (No) 6 (No) 36 (No) 10 (No) 32 (No) 20 (No) 22 (No)










Table 3 Associations between levels of vitamin B12, folate, vitamin D and homocysteine and measures of muscle strength, gait, balance and neuropathy (Continued)
Barthel Index of Activity
of Daily Living (maximum
score of 20)
19.62 ± 1.05 19.78 ± 0.49 ns 19.09 ± 1.37 19.87 ± 0.46 <0.01 19.64 ± 0.84 19.74 ± 0.77 ns 19.82 ± 0.48) 19.62 ± 0.98 ns
3 (<20) 6 (<20) 5 (<20) 4 (<20) <0.05 (Fish) 3 (<20) 6 (<20) 5 (<20) 4 (<20)
21 (=20) 26 (=20) 6 (=20) 41 (=20) 11 (=20) 36 (=20) 24 (=20) 23 (=20)
13 % (<20) 19 % (<20) 45 % (<20) 9 % (<20) 21 % (<20) 14 % (<20) 17 % (<20) 15 % (<20)
Lawton Instrumental
Activities of Daily Living
(maximum score of 8)
7 (<8) 4 (<8) ns 5 (<8) 6 (<8) <0.05 (Chi) 4 (<8) 7 (<8) ns 9 (<8) 2 (<8) <0.05
(Fish)
17 (=8) 28 (=8) 6 (=8) 39 (=8) <0.05 (Fish) 10 (=8) 35 (=8) 20 (=8) 25 (=8)
29 % (<8) 14 % (<8) 45 % (<8) 13 % (<8) 29 % (<8) 17 % (<8) 31 % (<8) 7 % (<8)
Performance-Oriented
Mobility Assessment–Balance
(POMA B) (maximum score of
16)
6 (<16) 10 (<16) ns 6 (<16) 10 (<16) <0.05 (Chi) 6 (<16) 10 (<16) ns 9 (<16) 7 (<16) ns
18 (=16) 22 (=16) 5 (=16) 35 (=16) ns, (Fish) 8 (=16) 32 (=16) 20 (=16) 20 (=16)
25 % (<16) 31 % (<16) 55 % (<16) 22 % (<16) 43 % (<16) 24 % (<16) 31 % (<16) 26 % (<16)
Performance-Oriented
Mobility Assessment–Gait
(POMA G) (maximum score
of 12)
8 (<12) 9 (<12) ns 6 (<12) 11 (<12) ns,
(0.05),(Chi)
5 (<12) 12 (<12) ns 8 (<12) 9 (<12) ns
16 (=12) 23 (=12) 5 (=12) 34 (=12) ns, (Fish) 9 (=12) 30 (=12) 19 (=12) 20 (=12)
33 % (<12) 28 % (<12) 55 % (<12) 24 % (<12) 36 % (<12) 29 % (<12) 30 % (<12) 31 % (<12)
Timed up-and-go test (s)
(average of two trials) (both
genders)
11.02 ± 5.02 10.01 ± 4.16 ns 14.17 ± 6.29 9.53 ± 3.52 <0.01 11.63 ± 6.37 10.05 ± 3.74 ns 10.70 ± 4.66 10.17 ± 4.45 ns
Timed up-and-go test (s)
(average of two trials) (men)
9.46 ± 2.67 9.56 ± 2.84 ns 11.59 ± 3.86 9.18 ± 2.43 ns 9.91 ± 3.98 9.44 ± 2.48 ns 9.52 ± 2.40 9.54 ± 3.16 ns
Timed up-and-go test (s)
(average of two trials)
(women)
12.33 ± 6.19 10.52 ± 5.34 ns 15.65 ± 7.17 9.93 ± 4.48 <0.05 12.58 ± 7.43 10.78 ± 4.83 ns 11.97 ± 6.11 10.75 ± 5.45 ns
6-m fast-gait speed (m/s)
(average of two trials) (both
genders)
1.07 ± 0.31 1.12 ± 0.26 ns 0.88 ± 0.30 1.15 ± 0.25 <0.01 1.03 ± 0.32 1.12 ± 0.27 ns 1.07 ± 0.28 1.12 ± 0.28 ns
6-m fast-gait speed (m/s)
(average of two trials) (men)
1.19 ± 0.29 1.16 ± 0.27 ns 1.00 ± 0.28 1.20 ± 0.27 ns 1.10 ± 0.28 1.19 ± 0.28 ns 1.17 ± 0.25 1.17 ± 0.31 ns
6-m fast-gait speed (m/s)
(average of two trials)
(women)
0.97 ± 0.29 1.06 ± 0.26 ns 0.81 ± 0.31 1.09 ± 0.23 <0.05 1.00 ± 0.34 1.03 ± 0.24 ns 0.97 ± 0.29 1.07 ± 0.26 ns
Values are the mean ± SD or number (%) unless otherwise indicated
VPT vibration perception threshold
Chi Chi-square test
Fish Fisher’s exact test










were vitamin D deficient, and a further 41.8 % were
vitamin D insufficient, with no significant difference in
vitamin D levels between those who were taking vitamin
D supplementation and those who were not [6]. These
results demonstrate the need for future studies of the
effects of age and diabetes mellitus on the bioavailability
of vitamin D supplements.
Folate deficiency was significantly associated with vita-
min B12 supplementation (P < 0.05). It is possible that
supplementation with relatively high doses of vitamin
B12, a common clinical practice, could drive up folate
metabolism and hence lead to folate deficiency (Fig. 3).
Indeed, five out of the seven patients in our cohort who
had vitamin B12 supplementation had been prescribed
Fig. 2 Serum levels of folate and measures of strength in individual patients. For each of the 28 female and 28 male participants, serum folate
was plotted against a the average leg strength (corrected for BMI) and b the average hand-grip strength (corrected for BMI)
Fig. 3 Functional relationships between vitamin B12, folate and homocysteine. dUMP, deoxyuridine monophosphate; dTMP, deoxythymidine
monophosphate; MS, methionine synthase; MTase, methyltransferase; MTHFR, methylenetetrahydrofolate reductase; SAHH, S-adenosylhomocysteine
hydrolase; TS, thymidylate synthase
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high doses of vitamin B12 in the form of either regular
intramuscular cyanocobalamin, oral methylcobalamin or
oral vitamin B12 in combination with vitamins B1 and
B6 (eg Neurobion®) (data not shown). Future studies of
the effect of vitamin B12 supplementation on folate
deficiency are needed.
To determine muscle strength, the convention is to use
the maximum dominant-limb measure from three at-
tempts. However, in our cohort, the average grip strength
and the average leg strength were measured instead, as we
believed, on a theoretical basis, that it would provide a
better assessment of overall strength by minimizing the
effect of unilateral limb pathology (such as a pre-existing
limb injury, severe osteoarthritis in the dominant limb or
occupational-use preference leading to an unusually
strong limb) that could skew the results. Moreover, the
maximal dominant-leg strength and maximal dominant-
grip strength were separately analysed in the sensitivity
analyses, and the results were similar to those obtained
with average-strength measurements (data not shown).
Folate levels were not significantly correlated with un-
adjusted leg-strength or grip-strength measures, and the
correlation was only evident when strength was cor-
rected for BMI (i.e. with BMI as the denominator) and
when men and women were analysed separately. This
correction is justified because, with all else being equal
(including height), a person with a greater body mass
and habitus is typically stronger than one with a lower
body mass [43, 56]. The analysis was, therefore, designed
to determine associations with strength, rather than
habitus. Many studies of strength measures do not make
this adjustment, with the possible result that significant
associations could have been missed.
The coefficients for the regression of folate on corrected
leg strength and on corrected grip strength were both 0.01
(Table 2), so that a difference of 10 nmol/l in folate
measurements would be associated with a variation in leg
strength or grip strength of BMI × 0.01 × 10. In two
women with BMI of 24 kg/m2, each 10 nmol/l difference
in folate would represent 2.4 kgf difference in strength.
This linear association was valid for the full range of folate
measurements, which extended from 6.0 to ≥56.2 nmol/l
(56.2 nmol/l was the upper limit of the folate assay), with
an overall mean of 21.5 ± 10.04 nmol/l. The correlation of
folate with strength had a greater variance in men than in
women (Fig. 2), possibly reflecting sexual dimorphism or
differences in occupation and recreational activities, and
their accompanying physical requirements. Although no
significant association was found between folate and
strength in men in our pilot study, this relationship should
be studied further with a larger sample size.
Corrected or uncorrected leg strength was, in turn,
negatively associated with the probability of having fallen
in the preceding year. With an OR of 0.89 for uncorrected
leg strength, a difference of 1 kgf would be associated with
an 11 % difference in the probability of having fallen (and
2.4 kgf, as discussed in the preceding paragraph, with 1–
0.892.4 = 24 % probability difference).
Vitamin D and vitamin B12 deficiencies and hyperho-
mocysteinaemia, as presented in the Background section,
have biologically plausible mechanisms that could account
for an observed reduction of muscle strength. In our co-
hort, trends toward poorer performance in strength mea-
surements, gait measurements, neurothesiometer scores
and history of falls were seen in patients with deficiencies
in vitamin B12, vitamin D and folate and with hyperho-
mocysteinaemia (Table 3). Whilst only folate deficiency
and hyperhomocysteinaemia yielded significantly poorer
scores in any of their respective measurements, the effects
of folate deficiency and hyperhomocysteinaemia seem to
be mediated through different pathways. For instance,
hyperhomocysteinaemia affected strength in men, whereas
folate deficiency had a greater effect on women than on
men. We suggest that the effect of folate deficiency on
strength and gait measurements involves biological mech-
anisms beyond the deleterious properties of homocysteine
per se. These mechanisms could include folate-specific
activities [57], such as neurotransmitter synthesis, myelin-
ation, synthesis of DNA and protein, DNA methylation
and epigenetic regulation (Fig. 3).
Our findings concur with those of a study of 796 re-
spondents in the Singapore Longitudinal Ageing Study,
which showed that low folate and high homocysteine
have independent associations with physical and func-
tional decline as measured by POMA and IADL scores
[26]. In a clinical trial [58] involving 92 patients in an
Australian residential home, 49 received multivitamins for
6 months, leading to increased levels of folate and corres-
pondingly decreased TUG times (r = −0.32, P = 0.043),
compared with untreated individuals. However, in a clin-
ical trial in the Netherlands [59] of individuals ≥65 years
old with hyperhomocysteinaemia, supplementation with
folate and vitamin B12 for two years did not reduce the
decline in hand-grip strength or prevent falls, relative to
placebo. The characteristics of this study population dif-
fered considerably from those of our cohort. The mean
height of the individuals in the intervention group, who
were predominantly European, was 169.4 ± 9.4 cm,
and the weight was 77.9 ± 13.3 kg, with a baseline
hand-grip strength of 30.8 ± 10.6 kgf. They were only
mildly hyperhomocysteinaemic (median homocysteine
14.5 μmol/l), with few vitamin B12-deficient or folate-
deficient individuals. BMI was not used as a denom-
inator for muscle-strength measures. Moreover, a
clinically beneficial effect of homocysteine reduction
through folate supplementation was seen on gait and
on physical-performance measures in a subgroup of
individuals >80 years old [59].
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The baseline values for muscle/grip strength can vary
between different ethnic/geographical groups. In our study
cohort, the mean grip strengths were 25.54 ± 7.78 kgf in
men (median 24 kgf) and 16.22 ± 3.29 kgf in women (me-
dian 16 kgf). These values are comparable to the means of
24.7 kgf for men and 16.5 kgf for women reported in a
Taiwanese population aged 70–74 years old [60], and are
within the thresholds of <26 kgf for men and <18 kgf for
women for initiation of sarcopenia assessment in Asian
populations [61]. In European populations, the cut-offs for
muscle strength are much higher than in Asian popula-
tions. In a Finnish study, the hand-grip-strength cut-
points to identify people ≥55 years old who were at risk
of mobility limitation were 37 kgf in men (without con-
sidering BMI) and 21 kgf in women [43]. In the Italian
InCHIANTI study, cut-offs for hand-grip strength of
30 kgf for men and 20 kgf for women were identified
[62]. Further studies are needed to enable us to under-
stand the role of folate deficiency in muscle weakness
in Asian populations, especially where mandatory forti-
fication of food with folate does not occur [63].
Limitations of this pilot study included the very small
sample size, which carries a risk for type II errors, and the
cross-sectional nature of the study, such that causality
cannot be determined from the identified associations.
The measurements of vitamin B12 and folate in this study
might not perform as well as indicators such as red-
blood-cell folate, methylmalonic acid [64] and methylene-
tetrahydrofolate reductase polymorphisms [65], which
were not investigated. Addition of the Lord swaymeter,
serum protein and albumin tests for the second phase of
the study resulted in the absence of results for the 11 pa-
tients who were included in the first phase, which reduced
the sample size for these assessments. Similarly, the use of
different instruments to measure leg strength in the first
phase and the second phase could have introduced a sys-
tematic error in leg-strength measurements between the
patients in the two phases, with the potential to introduce
a type I error and affect the internal validity. Indeed, the
average leg strength (corrected for BMI) for the first 11
patients was 0.699 ± 0.118 m2, and for the subsequent
45 patients was 0.961 ± 0.060 m2 (P = 0.06). The differ-
ence most likely reflects an earlier selection bias toward
recruitment of weaker patients. As only one patient
could be recruited at a time and often more than one
patient were simultaneously being referred for recruit-
ment, a preference for the recruitment of the weaker-
looking patient likely occurred due to the physical
strain of using the hand-held dynamometer in the first
phase of the study. Moreover, we did not perform a
formal statistical comparison between the two dyna-
mometers. However, some evidence suggests that the
leg strength measurements were valid. The instruments
were both calibrated to measure force in kgf, and the
examiner was able to fully resist the knee extension of all
the 11 patients in the first phase. Studies have generally
shown acceptable correlation of hand-held dynamometry
with standard isokinetic dynamometry [66], especially for
weaker, older people [42]. The average grip strength (cor-
rected for BMI) was measured using the same dynamom-
eter for patients in both phases, and folate predicted
corrected grip strength with a similar coefficient of regres-
sion as that with corrected leg strength. Finally, sensitivity
testing using bivariate analyses for each of the phases of the
study by gender showed that folate had a consistently posi-
tive but nonsignificant association with the corrected aver-
age leg strength, and that significance was attained only
after combining the data from the two phases.
Affective and cognitive function were not tested for-
mally in this study, even though these functions might
be confounding variables in falls. We presumed that the
recruitment process itself, involving motivation, cooper-
ation, understanding and informed consent, would
create a selection bias in favour of individuals who were
not depressed or demented. However, it is possible that
some of the patients included in our study did have
unidentified affective or cognitive disorders.
Conclusions
In a cohort of 56 patients >65 years old with diabetes
mellitus, serum levels of folate strongly and significantly
predicted muscle strength (corrected for BMI), especially
in women.
The effect of folate on strength was possibly mediated
less through homocysteine, and more through direct,
folate-specific mechanisms (such as myelination, neuro-
transmitter formation, synthesis of DNA and protein
and epigenetic methylation of DNA).
A clinical trial is warranted to investigate the role of fol-
ate in the aetiology of sarcopenia and falls, especially
where folate deficiencies are prevalent and food fortifica-
tion is not mandatory. This pilot study provides measures
of the prevalence and effect size of folate deficiency, to
facilitate the design of such a trial.
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